Aniiarrhylhmic Activity. Dogs with persistent ventricular tachycardia (24 hours or longer) were prepared, under aseptic conditions, by the two-stage coronary ligation method of Harris, 4 the ligatures being placed 0-5 mm. below the tip of the left auricular appendage. Activity of the drugs was tested without anesthesia or sedation, 15 to 20 hours after coronary ligation, by infusing the selected dose in 20 ml. of saline into the femoral vein in 5 minutes. At least 45 to 60 minutes were allowed between repeated injections. Femoral arterial pressure was measured with a Statham (P23-A) manometer and the three-limb ECG leads were recorded at frequent intervals on a multichannel direct writing oscillograph.
Electrocardiographic Changes and Conduction. The effects of both drugs in large doses were determined in dogs anesthetized with pentobarbital, (35 mg. per Kg.) and maintained with artificial respiration. The drugs were infused intravenously at a constant rate of 4 mg. per Kg. per min. (0.5 ml. per minute). The ECG was recorded frequently, and blood pressure continuously (Anderson manometer).
Threshold of Isolated Ventricular Strips from the right heart of the rat was determined by measuring the voltage required to elicit successive contractions to a square pulse of 0.1 millisecond duration while driving at a constant rate of 30 per minute. The cathode lead was imbedded in the tissue while the bath served as the anode. Contractility was recorded isometrically using a strain gauge and oscillograph. The strips were suspended in Locke's solution' buffered with NaHCOi and aerated with 95 per cent oxygen and five per cent COi to maintain a pH of 7.4. Drugs were introduced into the bath and threshold measurements made for 30 minutes or until equilibrium was reached.
Ventricular Excitability in the Intact Dog was measured throughout the cardiac cycle at 5-20 millisecond intervals by the two stimuli technic using instrumentation similar in operational principle to that of Suckling and coworkers. ' Using pentobarbital anesthesia, the heart was exposed and a plastic disc containing three stimulating electrodes was sutured to the base of the right ventricle; one electrode served as a common anode, and the others as the cathodes for the driving The ventricle was driven at a rate of 150 per minute from a stimulator with a 0.5 millisecond pulse delivered through an isolation transformer. This stimulator also drove an electronic frequency divider which on each tenth driving stimulus triggered a second stimulator to provide a 3 millisecond square wave test stimulus following a calibrated delay. A monopolar right ventricular electrogram observed on an oscilloscope indicated whether the heart responded to the test stimulus. The current in milliamperes was-calculated from the voltage drop (measured on an oscilloscope) across a 100 ohm resistor in the cathode side of the test lead.
AXTIARRHYTHMIC ACTION OF AMBONESTYL -The Effect of Ambonesti/l (MC 41IS) in Dogs vrith Persistent Ventricular Ectopic Rhythm (VER)
Excitability curves were obtained at 30 minute intervals before and after administration of the drug. The heart was driven for 5 minutes before each test, which took 10-15 minutes, and the driving stimulus was otherwise cut off between determinations.
Other Tests. The following methods were used for some of the tests in table 3: local anesthetic action on isolated nerve 7 and intradermal wheal ; 8 ganglionic blockade in the cat superior cervical ganglion; 9 and LDw in mice."
RESULTS

AiUiarrhytlwiic
Activity. The arrhythmia tsuppressive activity of Ambonestyl was tested in nine unanesthetized clogs with an ectopic ventricular tachycardia resulting from coronary ligation. The average single dose was 40 nig. per kilogram intravenously. Two dogs received one dose of the drug, five were given two doses, and two received three or more injections. The results shown in Table 1 indicate a reduction in the total ventricular rate with •each dose in every dog. The ventricular ectopic rhythm was completely suppressed with convcraion to normal sinus rhythm in four dogs (C-43, C-45, C-46, C-48). In five animals the •conversion was incomplete, but the rate of the ventricular ectopic activity was reduced. Repeated administration of Ambonestyl usually produced a greater reduction in the ventricular •ectopic rate. As part of another study by one of us (BBC), the drug was tested in an additional series of 8 dogs with essentially the same results. The characteristic electrocardio- The duration of action of Ambonestyl appeared to be longer than that of procaine amide. Twelve experiments show that the concentration of Ambonestyl had to be approximately 10 times that of procaine amide to achieve an equivalent elevation of threshold (table 2) . Lower concentrations corresponding to threshold elevating doses of procaine amide were without any significant effect. Neither drug affected contractility adversely in these concentrations.
J'Jlectrocardiographic Changes and Conduction in Normal Anesthetized Dogs.
Ventricidar Excitability and Refractory
Period. Three control strength-interval curves were determined and then Ambonestyl was injected intravenously over a 5 minute period and excitability curves repeated every 30 minutes until control values were approached. The blood pressure prior to the administration of the drug ranged from 100 to 130 mm. Hg, and was lowered only 5 to 10 mm. Hg by Ambonestyl.
Technically acceptable experiments were obtained in 5 dogs; three of the animals received 40 mg. per Kg., one 50 mg. per Kg, and another 60 mg. per Kg. As figure 4 illustrates, there wasno significant change in the diastolic electrical threshold in any of the dogs. In all animals, however, there was an increase in the refractory period. The increase ranged between 10 to 40 milliseconds, a change which appears statistically significant since variation in control curves was not greater than five milliseconds. The change in the absolute refractory period appeared to be larger and more consistent than the change in the relative refractory period. The refractory period always increased to the greatest extent shortly after administration of the drug, and then progressively decreased over a period of time (one to one and one-half hours) to approximate the control value.
The results in three preliminary experiments in which the heart was driven alternately at ) and procaine amide on the response to vagal stimulation and carotid occlusion. The animals were anesthetized with pentobarbital. The peripheral end of the divided right vagus was stimulated every 6 minutes for 10 seconds, and alternately the carotid arteries were bilaterally occluded for 30 seconds, every 6 minutes. The drugs were injected intravenously.
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rates of 150 and 240 clearly indicated about the same increase in refractory period at the two rates, but, more important, they showed that the drug did not prevent the physiologic .shortening which occurs with higher driving rates.
Specificity of Anliarrhytkmic Action. Exnmination of Ambonestyl for other pharmacological actions which have been correlated with various antiarrhythmic agents 12 ' " revealed that it had (1) no local anesthetic, (2) no udrenolytic or sympatholytic, (3) no atropineJike and (4) no antihistaminic activity (table  . 3). The vagal depressing ( fig. 5 ) and ganglionic blocking actions were evident only in large doses approximately three times those of procaine amide.
Toxicity. Central nervous system toxicity was either absent or relatively mild in the unnnesthetized coronary dog at effective doses of 40 mg. per Kg. (table 1) . More pronounced head and occasionally body tremor were observed with larger doses (table 3) , but no frank convulsions were seen. In dogs, the intensity and duration of the central toxicity Avaa slightly greater than that observed with procaine amide, but the acute toxicity was somewhat less in the monkey and mouse {table 3).
Bloml Pressure. In the unanesthetized coronary clog, the blood pressure usually remained unaffected with the doses of Ambonestyl required to suppress the arrhythmia; however, in some experiments either a slight increase or decrease was observed (figs. 1 and 2). On the other hand, procaine amide more frequently produced a slight decrease. The changes, however, with either agent were not particularly significant.
Under barbiturate anesthesia both drugs produced some fall in blood pressure, but the degree of hypotension seen following 20 to 60 mg. per Kg. doses was consistently less with Ambonestyl ( fig. 5 ). It seems likely that this difference may be due largely to the weaker ganglionic blocking activity of Ambonestyl (table 3) . In those experiments where large doses were given by continuous infusion ( fig. 3 ) both drugs decreased heart rate and lowered blood pressure. Following the completion of the infusion of Ambonestyl (320 mg. per Kg., total dose) the heart rate and blood pressure tended to return toward control values, whereas with procaine amide no trend toward the control levels was noted during the same period of observation.
DISCUSSION
The results have shown that Ambonestyl is as effective in suppressing experimental ventricular tachycardia as procaine amide, but is pharmacologically more specific since it does not depress cardiac conduction, does not elevate ventricular electrical threshold, and produces less hypotension. This latter finding will be of clinical interest, since the frequent production of hypotension is a limiting factor in the intravenous use of procaine amide.
14 ' " Cardiac conduction is not depressed by Ambonestyl and this is important since depression of conduction may occur with the use of both procaine amide and quinidine especially in patients with intraventricular conduction disturbances. 19 
'
17 Ambonestyl also did not significantly affect electrical threshold. In contrast, procaine amide does increase the threshold of the intact dog ventricle. 18 The results with Ambonestyl thus suggest that neither elevation of threshold nor depression of cardiac conduction is essential to antiarrhythmic action.
The fact that Ambonestyl increases the refractory period to some degree without changes in conduction and threshold is of some interest in itself. The role of an increase in refractory period is by no means clear. This effect per se would appear only to delay the appearance of a premature beat by a small fraction of the cardiac cycle. Furthermore since Ambonestyl does not prevent the physiological shortening of the refractory period due to an increase in driving rate, a persistently firing ectopic focus should still be effective in activating the ventricle. Ambonestyl must then act more directly in suppressing the activity of the ectopic pacemaker. The mechanism of this effect is, as yet, unknown.
Several workers 12 ' "• 1 9' i0 have suggested a possible direct correlation between local anesthetic activity and antiarrhythmic activity. The complete lack of local anesthetic activity in Ambonestyl lends no support to this view. On the other hand it seems more likely that local anesthetic activity may contribute to the depression of cardiac conduction. 18 ' !0
Since the above studies do not provide an adequate explanation of the mechanism of action of Ambonestyl it seems likely that the mode of action may be more closely related to factors controlling cellular trans-membrane potentials which do not manifest themselves in changes in threshold and conduction. That there is some alteration in cellular recovery processes may be implied from the increase in the refractory period and the reduction in the height of the T wave.
Preliminary studies in man have so far corroborated these experimental studies and are being reported elsewhere. 21 
SUMMARY
Ambonestyl is as effective as procaine amide in suppressing ventricular tachycardia occurring in dogs following coronary occlusion. The overall toxicity is less than that of procaine amide.
The degree of hypotension observed with Ambonestyl is definitely less than with procaine amide, and its ganglionic blocking activity is also less.
Ambonestyl does not depress cardiac conduction, nor elevate the diastolic electrical threshold of the ventricle as does procaine amide. The only effect demonstrated on normal heart tissue is a small increase in refractory period.
Ambonestyl seems to be quite specific in its cardiac actions, lacking any local anesthetic, adrenolytic or sympatholytic actions.
